The story of a miracle: affected by multiple sclerosis, she walks again thanks to the CBD
When Anat Avisar Koren (37 years old) became pregnant, the bureaucracy withdrew her authorization to consume medical cannabis that she regularly used to relieve pain. This decision resulted in the collapse of Anat's condition and within two weeks she found herself in a wheelchair unable to walk, probably for the rest of her life. The doctors diagnosed multiple sclerosis (MS), a potentially disabling neurological disease of the brain and spinal cord (central nervous system).
Anat's condition quickly worsened, so she was pregnant, suffering, and disabled. Anat decided to fight the attack of MS. However, she quickly discovered that there is no cure, that there is virtually no information online and that there is no medical solution to her desire to walk again and again. 'to be a normal mother' for her daughter.
She began to study the field of nutrition and dietary supplements alone; she used her own body as a guinea pig and in a few months she discovered a combination of vitamins and CBD oils that managed to get an incredible result: Anat could get up from her wheelchair and walk again.
The nutritional combination LifeAid combo, which includes CBD oil (Cannabidiol), various combinations of vitamins, such as B12 and D, and herbal extracts (all ingredients are FDA approved as food supplements).
"The doctors said that I probably could not walk anymore," says Anat Avisar Koren. "I laughed and started working to get out of the wheelchair. It took a few months and I was right. They were wrong. "
The story of Anat's success was something she wanted to share with other patients with autoimmune diseases around the world. She decided to do some research to test with other people who are suffering. She invented the LifeAid combo, anti-autoimmune power capsules, dosed with 65% CBD and combining the various dietary supplements that helped her. 1 349 participants have tried the LifeAid Combo components twice daily for 3 months. The study included participants in 5 autoimmune test groups (Guillain-Barré + SEP - 248 patients, rheumatoid arthritis - 107 patients, Crohn's disease - 98 patients, asthma - 435, vasculitis - 150 patients) and 1 control group (fibromyalgia - 311). The data were collected by the patients themselves using a daily questionnaire and supervised by the YU research center, doctors and pharmacists - Batya Kornbaum and Baruh Styr.
The research showed exceptional results, among them: 72% of patients with rheumatoid arthritis had an improvement in pain, 65% of patients with MS had improved mobility and 61% of patients with Crohn's disease reported having slept all night (for complete results see the attached chart). The number of seizures dropped to 0 among all participants. In addition, the following percentage of participants in each group showed a significant improvement in the respective health aspects during the 100 days following participation in the LifeAid combo (P <0,001, Pearson test):
|Guillain-Barré + SEP||Polyarthrite rhumatoïde||Crohn's disease||Asthma||vasculitis||fibromyalgia|
NP: Not relevant
The introduction of LifeAid Combo has been associated with a substantial improvement in the health of all groups.
CBD and dietary supplements bring hope
Autoimmune diseases are the new epidemic in the Western world as 10% of the world's population suffers from chronic autoimmune diseases. Unfortunately, the treatment today includes drugs that have a risk of serious side effects that sometimes almost exceed the damage caused by any autoimmune disease (steroids, for example, have been linked to viral infections, HPV and even to cancer). Without patient testimonials, none of this would have been known, and most of them have not been reported by the FDA during the drug approval process. Patients are becoming the best experts of their own body, especially those with chronic ailments accumulating decades of experience. Anat and 1 349 patients are living proof of the effectiveness of CBD oil associated with the right amount of vitamins.
Coming soon, she will present her results at the Multiple Sclerosis Congress in Amsterdam, and tell her story. She will be the first person not to be from the medical profession to speak at this congress.